Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2021-02-18 2021-01-15
Drug Identification Number 02439255 02439255
Brand name ACT AMPHETAMINE XR ACT AMPHETAMINE XR
Common or Proper name AMPHETAMINE XR 15MG CAP AMPHETAMINE XR 15MG CAP
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients MIXED SALTS AMPHETAMINE MIXED SALTS AMPHETAMINE
Strength(s) 15MG 15MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N06BA N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-01-13 2021-01-13
Estimated end date 2021-03-31 2021-02-28
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments